Gujarat Terce Laboratories Limited has amended its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information to align with the recent amendments to the SEBI (Prohibition of Insider Trading) Regulations, 2015. The revised code, effective from 29 May 2026, supersedes the earlier version and aims to ensure prompt, uniform, and adequate disclosure of information that could materially affect the price of its securities.

The company has designated its Company Secretary & Compliance Officer, Ashka Solanki, to also act as the Chief Investor Relations Officer (CIRO). The CIRO is responsible for ensuring timely dissemination of Unpublished Price Sensitive Information (UPSI) to stock exchanges, analysts, and the media to prevent selective disclosure. The code mandates that any UPSI shared with analysts or institutional investors must be made public simultaneously to maintain transparency.

Key Provisions of the Amended Code

The amended code defines UPSI to include financial results, dividends, changes in capital structure, mergers, acquisitions, key managerial personnel changes, and regulatory actions. It establishes a structured digital database to track the sharing of UPSI, ensuring that records are maintained for at least eight years. The policy also outlines conditions for sharing UPSI for "Legitimate Purposes," such as with partners, lenders, or legal advisors, provided it is done on a need-to-know basis and not to circumvent trading regulations.

Compliance and Governance

Gujarat Terce Laboratories Limited's Board of Directors adopted the revised code on 29 May 2026. The code will be reviewed annually, and any amendments to statutory or regulatory requirements will be binding immediately. The company has clarified that it is not among the top 100 or 250 listed entities by market capitalization, so its response to market rumors under Regulation 30(11) of the SEBI Listing Regulations remains voluntary.

Gujarat Terce Laboratories has scheduled its 41st Annual General Meeting (AGM) for Friday, August 21, 2026. The decision was taken by the Board of Directors during a meeting held on May 29, 2026. The company has established a cut-off date to determine shareholder eligibility for e-voting and participation in the meeting.

The cut-off date for determining eligibility has been fixed as August 14, 2026. Members whose names appear in the register of members on this date will be entitled to participate in the AGM and cast their votes through the e-voting facility. The intimation was submitted to BSE Limited pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The disclosure was formally communicated by Ashka Solanki, Company Secretary of Gujarat Terce Laboratories Limited. The filing confirms that the regulatory procedural requirements for intimating the stock exchange regarding the AGM schedule have been complied with.